Compare Edwards Lifesciences Corporation Common Stock (EW) vs iShares Core MSCI Emerging Markets ETF (IEMG) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Edwards Lifesciences Corporation Common Stock vs iShares Core MSCI Emerging Markets ETF — how do they compare? Edwards Lifesciences Corporation Common Stock trades at $85.07 (market cap $48.56B), while iShares Core MSCI Emerging Markets ETF trades at $81.14 (market cap $162.00B). The key difference: iShares Core MSCI Emerging Markets ETF is far larger — about 3.3× Edwards Lifesciences Corporation Common Stock's market cap, and iShares Core MSCI Emerging Markets ETF is trading nearer its 52-week high, Edwards Lifesciences Corporation Common Stock nearer its low. Which is the better fit depends on your goals.
| EW | IEMG | |
|---|---|---|
Market Cap | $48.56B | $162.00B |
Volume | 6,520,488 | 13,446,151 |
Sector | Health | Broad Market / Factor |
52-Week High | $95.18 | $86.00 |
52-Week Low | $72.65 | $64.22 |
Enterprise Value | $45.01B | — |
Typical Hold Time | — | 57 Days |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
No Aura AI signal available yet.
IEMG trades at $82.04, down 1.2% on the day, with a bullish technical signal driven by moving averages. The emerging markets ETF has demonstrated strong performance with 35% returns over the past year, though it faces higher volatility than broader international alternatives. Recent news highlights IEMG's significant technology sector exposure (39%) and competitive positioning against peers like SCHE and VWO.
The outlook remains positive given emerging markets momentum and record capital inflows, though investors face currency risk and concentration concerns. IEMG's 0.09% expense ratio provides cost efficiency for emerging markets exposure, but the fund's heavier tech weighting and historical drawdowns require careful risk management in volatile market conditions.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
No sentiment data available yet.
About Edwards Lifesciences Corporation Common Stock
Edwards Lifesciences develops medical technologies for structural heart disease. Its products include transcatheter aortic-valve replacement, mitral and tricuspid therapies, and surgical structural-heart technologies.
Read more on EW →About iShares Core MSCI Emerging Markets ETF
IEMG tracks the MSCI Emerging Markets Investable Market Index, providing broad exposure to large, mid, and small-cap stocks across over 20 emerging market countries. It is designed as a low-cost core holding for investors seeking diversified growth from economies outside of developed markets.
Read more on IEMG →
